Gorlin Syndrome clinical trials

Explore recruiting gorlin syndrome clinical trials.

Recruiting gorlin syndrome studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gorlin Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Randomized, Double blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Gel 2% for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects with Gorlin Syndrome

Netherlands, France, Italy, Spain, Poland, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase II study of Sonidegib in Nevoid Basal Cell Carcinoma Syndrome (Gorlin) syndrome and sporadic BCC patients in EADO stage IIb. SIBLINGS TRIAL

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB)

France, Denmark, Germany, Belgium, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Gorlin Syndrome trials by city

Gorlin Syndrome in Toronto Gorlin Syndrome in Vancouver Gorlin Syndrome in Montreal Gorlin Syndrome in Calgary Gorlin Syndrome in Edmonton Gorlin Syndrome in Ottawa Gorlin Syndrome in Winnipeg Gorlin Syndrome in Quebec City Gorlin Syndrome in Hamilton Gorlin Syndrome in Kitchener Gorlin Syndrome in London Gorlin Syndrome in Halifax Gorlin Syndrome in New York Gorlin Syndrome in Los Angeles Gorlin Syndrome in Chicago Gorlin Syndrome in Houston